Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
7.02
+0.04 (0.57%)
Oct 6, 2025, 4:00 PM EDT - Market closed
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $160.91 million as of October 6, 2025. Its market cap has increased by 5.24% in one year.
Market Cap
160.91M
Enterprise Value
154.42M
1-Year Change
5.24%
Ranking
Category
Stock Price
$7.02
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has increased from $152.13M to $160.91M, an increase of 5.77%. That is a compound annual growth rate of 5.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 159.99M | 2.91% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |